期刊
NEUROBIOLOGY OF STRESS
卷 11, 期 -, 页码 -出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ynstr.2019.100196
关键词
Allopregnanolone; Brexanolone; SGE-217; Steroid enantiomers; Tonic inhibition
资金
- Taylor Family Institute for Innovative Psychiatric Research
- Bantly Foundation
- Sage Therapeutics
- [MH101874]
- [MH114866]
- [MH110550]
- [AA026753]
The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with major depressive disorder offer the hope of a new era in treating mood and anxiety disorders based on the potential of neurosteroids as modulators of brain function. This review considers potential mechanisms contributing to antidepressant and anxiolytic effects of allopregnanolone and other GABAergic neurosteroids focusing on their actions as positive allosteric modulators of GABA(A) receptors. We also consider their roles as endogenous stress modulators and possible additional mechanisms contributing to their therapeutic effects. We argue that further understanding of the molecular, cellular, network and psychiatric effects of neurosteroids offers the hope of further advances in the treatment of mood and anxiety disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据